Shinsung E&G Visit iAir Lab Facility to Explore Collaboration on Cleanroom and Air Quality Solutions
article on Shinsung E&G visit by by Anna O’Donovan
Exploring Cleanroom Innovation: Shinsung E&G at Airmid Healthgroup
On Thursday 25th September 2025, Airmid Healthgroup was pleased to welcome visitors from Shinsung E&G to our Dublin laboratories. The visit was arranged following an introduction at the Korean Cleantech Companies Networking Lunch hosted by Enterprise Ireland.
Visitors included:
-
Mr. Jae Hong Paeng, Team Leader, Technology Innovation Division, Shinsung E&G
-
Mr. Taewon Um, Director Korea, Enterprise Ireland
Purpose of the Visit
The Shinsung team were invited to Airmid Healthgroup by CEO Dr. John Ryan to explore potential opportunities for collaboration. Our technical teams identified several areas of mutual interest where Airmid’s accredited testing expertise could support Shinsung’s cleanroom and air system technologies.
Key discussion topics included:
-
Airflow and particle visualisation tests – potential collaboration on advanced testing methodologies.
-
Gas analysis equipment – approaches to measuring volatile compounds in controlled environments.
-
System validation – opportunities for Airmid to test and validate Shinsung cleanroom and air systems, particularly for microbial and pathogen control.
-
Post-installation services – support for ongoing monitoring and periodic re-certification of cleanroom and air systems.
-
Market expansion – leveraging Airmid’s ISO/IEC 17025 accreditation to help Shinsung access regulated markets while enabling Airmid to broaden its client base and data resources.
Areas of Particular Interest
The discussions highlighted Shinsung’s focus on managing VOCs in their manufacturing facilities, as well as their interest in understanding how best to test both VOCs and particles emitted during the manufacture, installation, and post-assembly phases of cleanroom panels and systems.
Opportunities for Future Collaboration with Shinsung E &G
One promising area identified was the potential for Airmid to test Shinsung cleanroom panels, which are manufactured using glass wool. With Airmid’s prior experience in testing and certifying glass wool products for Knauf, this represents a strong opportunity for partnership.
The visit concluded with a lab tour, where the Shinsung delegation viewed Airmid’s aerobiology chambers, environmental testing systems, and validation equipment, providing them with insight into how scientific testing underpins the delivery of healthier indoor environments.
We look forward to further discussions with Shinsung E&G and Enterprise Ireland to develop this exciting collaboration.
Related Blogs
A Review of the ASHRAE Ireland Chapter Meeting at Airmid
Inside Airmid’s State-of-the-Art Aerobiology Test Chambers
ASHRAE Indoor Air Quality: Dennis Knight Explores the Future at Airmid Healthgroup
Related Tests at Airmid Healthgroup
Aerobiology Test Chambers: Laboratory Testing Services
28.5 m³ Environmental Test Chamber
30m³ Environmental Test Chamber
3 m³ Environmental Test Chamber
Word Tags
Shinsung E&G, Airmid Healthgroup, cleanroom systems, VOC analysis, airflow testing, particle visualisation, ISO/IEC 17025, glass wool, Knauf, Enterprise Ireland, international collaboration, indoor air quality
About iAIR Health Labs and Airmid
Airmid Healthgroup is a world-leading biomedical contract research organisation (CRO) specialising in aerobiology, infectious aerosols, allergy science, and indoor air quality (IAQ). We help global brands, medtech developers, and standards organisations bring healthier, safer, and performance-verified products to market, backed by robust, peer-reviewed science. From GLP-compliant infection control studies to real-world validation of air cleaning technologies, we operate at the intersection of public health, product innovation, and regulatory science. Our purpose-built test chambers and ISO 17025-accredited laboratories allow us to simulate real-life conditions in homes, hospitals, schools, aircraft cabins, and more, providing clients with the scientific evidence and market confidence they need.
